RxDoctor Payments Data

John Williams, MD

Family Medicine · Yadkinville, NCNPI 1073574604

Payments from drug & device makers

$503in general payments, 2019–2025

Across 29 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$171
  • Insulet Corporation$49
  • Johnson & Johnson$47
  • AstraZeneca$46
  • Abbott$36
  • AbbVie$36
  • plus $117 from 5 others

What the payments were for

  • Food & beverage$503100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$503 in reported general payments places this provider in the 55th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$13,929
Medicare patients
50
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide64$104,039
JardianceEmpagliflozin44$55,013
EliquisApixaban53$36,655
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$31,597
FarxigaDapagliflozin Propanediol45$26,981
VraylarCariprazine Hcl12$17,375
MounjaroTirzepatide12$12,194
Spiriva HandihalerTiotropium Bromide18$10,312
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,789
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$6,983
SymbicortBudesonide/Formoterol Fumarate21$6,569
Febuxostat21$4,640
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen113$4,555
CreonLipase/Protease/Amylase13$4,161
Advair HfaFluticasone Propion/Salmeterol12$3,508

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$171$104,03964 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$46$41,33978 claims
AbbVieVraylar, Creon, Synthroid$36$23,31343 claims
Lilly USA, LLCMounjaro$16$12,19412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Yadkinville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →